Niemann-Pick Type C Treatment With Adrabetadex for Symptoms of Brain and Nervous System

NCT03643562 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
27
Enrollment
INDUSTRY
Sponsor class

Stopped Sponsor had determined that the benefit-risk profile of adrabetadex was not favorable and the clinical development program for adrabetadex was discontinued.

Conditions

Interventions

Sponsor

Mandos LLC